$18.4B
$5,000
0.0% of portfolio
30
Q1 2025
New
$24.6B
$0
0.0% of portfolio
4
Q2 2025
Reduced 77.78%
$73.5B
$37,000
0.0% of portfolio
356
Q2 2025
Added 16.72%
$19.4B
$11,000
0.0% of portfolio
22
Q2 2025
Added 4.76%
$0
$21,000
0.0% of portfolio
320
Q2 2025
Added 13.88%
$10.2B
$44,000
0.0% of portfolio
2,200
Q2 2024
Added 83.33%
$24B
$6,000
0.0% of portfolio
35
Q2 2025
Added 483.33%
$3.44B
$4,000
0.0% of portfolio
135
Q1 2024
Reduced 28.57%
-
$0
0.0% of portfolio
-
Q1 2024
Added 30.99%
$1.27T
$22,000
0.0% of portfolio
100
Q4 2024
Reduced 4.76%
$1.74B
$12,000
0.0% of portfolio
371
Q3 2024
Added 40.0%
$0
$8,000
0.0% of portfolio
487
Q1 2023
New
$3.56B
$14,000
0.0% of portfolio
114
Q4 2021
New
$14.1B
$40,000
0.0% of portfolio
91
Q3 2024
Reduced 1.09%
$56.9B
$10,000
0.0% of portfolio
330
Q2 2025
Reduced 34.65%
$182B
$20,000
0.0% of portfolio
38
Q2 2024
Reduced 24.0%
Structure Therapeutics Inc Sponsored Ads
-
$0
0.0% of portfolio
-
Q4 2023
New
$61.1B
$36,000
0.0% of portfolio
452
Q2 2025
Added 4.63%
$12.2B
$8,000
0.0% of portfolio
86
Q2 2025
Added 43.33%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 12.07%
$7.21B
$5,000
0.0% of portfolio
22
Q3 2024
Reduced 29.03%
Brookfield Asset Management
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.0%
$7.99B
$0
0.0% of portfolio
2
Q2 2025
Reduced 95.92%
Ge Healthcare Technologies
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.1%
$765M
$2,000
0.0% of portfolio
294
Q1 2024
Added 44.12%
Genedx Holdings Corp Com Cl A
-
$0
0.0% of portfolio
-
Q1 2025
New
$69.2B
$24,000
0.0% of portfolio
203
Q1 2025
Added 13.41%
$19B
$12,000
0.0% of portfolio
100
Q2 2023
Reduced 16.67%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 0.38%
$1.61B
$2,000
0.0% of portfolio
184
Q1 2025
New
$51B
$42,000
0.0% of portfolio
571
Q3 2023
Reduced 10.5%
$14.9B
$1,000
0.0% of portfolio
33
Q2 2025
New
Brookfield Infra Partners Cl A
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 3.53%
$40.9B
$18,000
0.0% of portfolio
250
Q1 2025
Reduced 56.75%
$8.29B
$12,000
0.0% of portfolio
249
Q2 2025
Added 4.62%
$12.3B
$6,000
0.0% of portfolio
35
Q2 2025
Reduced 55.13%
Nebius Group N.V. Shs Class A
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 59.31%
-
$0
0.0% of portfolio
-
Q2 2025
Added 313.95%
$0
$19,000
0.0% of portfolio
169
Q4 2024
Added 0.6%
$4.09B
$4,000
0.0% of portfolio
477
Q1 2024
Reduced 59.13%
$4.44B
$7,000
0.0% of portfolio
77
Q2 2025
Reduced 28.04%
$33.7B
$14,000
0.0% of portfolio
575
Q4 2024
Added 400.0%
$32.7B
$51,000
0.0% of portfolio
600
Q2 2025
Added 1,566.67%
$86.8B
$36,000
0.0% of portfolio
254
Q2 2025
Added 2.83%
$0
$41,000
0.0% of portfolio
192
Q2 2025
Reduced 11.52%
$76.9B
$31,000
0.0% of portfolio
635
Q2 2025
Added 11.01%
$93.6B
$35,000
0.0% of portfolio
69
Q4 2024
Reduced 58.93%
$14.4B
$4,000
0.0% of portfolio
196
Q1 2025
Added 880.0%
$1.46B
$9,000
0.0% of portfolio
322
Q4 2023
Added 30.89%
$13.4B
$7,000
0.0% of portfolio
133
Q2 2025
Added 9.92%